z-logo
open-access-imgOpen Access
Whole‐exome sequencing identified novel compound heterozygous variants in a Chinese neonate with liver failure and review of literature
Author(s) -
Qin Zailong,
Yang Qi,
Yi Shang,
Huang Limei,
Shen Yiping,
Luo Jingsi
Publication year - 2020
Publication title -
molecular genetics and genomic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.765
H-Index - 29
ISSN - 2324-9269
DOI - 10.1002/mgg3.1515
Subject(s) - exome sequencing , hyperlactatemia , compound heterozygosity , medicine , sanger sequencing , missense mutation , exome , genetic testing , hypoglycemia , bioinformatics , genetics , dna sequencing , phenotype , biology , gene , insulin
Background Liver failure caused by TRMU is a rare hereditary disorder and clinically manifests into metabolic acidosis, hyperlactatemia, and hypoglycemia. Limited spectrum of TRMU pathogenic variants has been reported. Methods Whole‐exome sequencing was employed for the diagnosis of a 5‐day‐old female who suffered from severe neonatal hyperlactatemia and hypoglycemia since birth. Sanger sequencing was performed to confirm the origin of the variants subsequently. Variants classification was followed to ACMG guideline. Results A compound heterozygosity of a frameshiftc.34_35dupTC (p.Gly13fs) and a missense c.244T>G (p.Phe82Val) in TRMU was detected, both variants are novel and pathogenic. Analysis of clinical and genetic information including patients reported previously indicated that there is no significant correlation between the genotype and the phenotype of TRMU‐caused liver failure. Conclusion To the best of our knowledge, this is the first case report of TRMU‐caused liver failure in China. Whole‐exome sequencing is effective for conclusive diagnosis of this disorder and beneficial for its clinical management.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here